I Amlan Bishal would like to present myself to work in your esteemed organization in light of my qualification and experience. Having 2year 1 months (July 2016 to August 2018) experience in Formulation Research and Development at Medopharm Pvt. Ltd. Chennai and then 1year 5months working experience (August 2018 to December 2019) as an Officer – Formulation & Development in Zuventus Healthcare Ltd. Sikkim. After that I worked at Aristo Pharmaceutical Pvt Ltd, Mandideep, Bhopal, Madhya Pradesh since January 2020 to October 2020 at Formulation Research and Development. Presently I am working as an Associate Professor at Bharat Technology, Uluberia, Howrah from November 2020 to present and also, I am Pursuing PhD from Maulana Abul Kalam Azad University of Technology (MAKAUT) Total I have got 4years 5months experience in Formulation R&D and Technology Transfer and have 5 years 2 month experience in academics as a teaching professional.
EDUCATION
M.Pharm in Pharmaceutics and Ph.D. (Pursuing) at MAKAUT
RESEARCH, TEACHING, or OTHER INTERESTS
Pharmacy, Drug Discovery, Pharmaceutical Science, General Pharmacology, Toxicology and Pharmaceutics
AI technologies for drug repurposing: methods and applications Kazi Asraf Ali, Sabyasachi Choudhuri, Sanjit Kr. Roy, Pradyot Kumar Roy, Amlan Bishal, Rideb Chakraborty, Tanushree Das Revolutionizing Drug Development Harnessing AI and Computational Biology, 2026
Stem Cell Therapy: A Significant Therapeutic Approach in Wound Healing Richa Dayaramani, Soma Jana, Bratati Bandyopadhyay, Amlan Bishal, Subhashis Debnath Stem Cell Therapy in Dermatological Disorders, 2025 Wound healing is a dynamic, complex biological process that comprises hemostasis, inflammation, proliferation, and remodeling of tissue. Despite the progress in traditional therapeutic regimens, nonhealing and chronic wounds remain a recalcitrant clinical issue, resulting in impaired quality of life and increased healthcare costs. Stem cell therapy has been hailed as a breakthrough therapy with its regenerative and tissue repair potential, anti-inflammatory action, and the ability to modulate the wound microenvironment. Stem cells, namely, mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs), possess certain unique features such as self-renewal, differentiation, and paracrine signaling, which serve as the foundation for tissue regeneration and repair. The review highlights the mechanism of stem cell–treated wound healing, with focus on their roles in angiogenesis induction, extracellular matrix remodeling, immune modulation, and epithelialization. The recent developments in stem cell delivery systems, including hydrogels, scaffolds, and exosome-based therapy, are highlighted as the focus to enhance their therapeutic potential. The limitations of stem cell therapy, including immunogenicity, scalability, and regulation, are critically evaluated. Current trends, including gene editing and bioprinting, are highlighted for the potential to further enhance stem cell–based therapies. In conclusion, stem cell therapy has the potential to be a revolutionary treatment for acute and chronic wounds and opens the door to personalized and regenerative medicine. Further research and clinical advancements are required to overcome the current limitations and achieve the maximum therapeutic potential of stem cells in wound healing.
Physical and mechanical evaluation of medical devices Kazi Asraf Ali, Tapan Kumar Shaw, Srimanta Sarkar, Amlan Bishal, Rupam Mukherjee, Chowdhury Mobaswar Hossain Medical Devices in Modern Healthcare Current Research on New Materials and Engineering Device Evaluation and Regulatory Implications, 2025
Approaches of AI and Advanced Computational Biology for Combating HIV Infections Kazi Asraf Ali, Sabyasachi Choudhuri, Amlan Bishal, Tanushree Das, Subhrajyoti Nandy, Chowdhury Mobaswar Hossain AI and Precision Medicine in Infectious Disease Management, 2025 Human immunodeficiency virus (HIV) remains one of the most challenging global health threats, requiring innovative approaches to understand and control its complex mechanisms. This chapter focuses on how computational biology technologies are transforming HIV research and treatment. AI-driven techniques such as machine learning, structural biology modeling, and genomic analysis enable researchers to analyze vast datasets, identify viral mutation patterns, and optimize drug design for higher efficacy and safety. In computational biology, the application of bioinformatics and systems biology provides new perspectives on HIV pathogenesis and immune evasion tactics. This chapter reviews significant advancements in predicting drug resistance, enhancing personalized treatment strategies, and discovering novel therapeutic targets. AI algorithms are also playing a pivotal role in vaccine development by simulating immune responses, accelerating the discovery of broadly neutralizing antibodies, and enabling a more targeted approach to vaccine design. Despite these advancements, challenges such as data privacy, ethical considerations, and the need for robust, unbiased algorithms persist. This chapter addresses the technical, ethical, and practical dimensions of applying AI and computational biology in HIV research for a multidisciplinary approach that combines computational insight with human empathy.
Microneedles: An Efficient Technique to Increase Transdermal Drug Delivery System Sanjit Kr. Roy, Kazi Asraf Ali, Mahua Biswas, Abhijit Dey, Amlan Bishal, Abhradeep Kuiry Current Drug Delivery, 2025 Transdermal Drug Delivery Systems (TDDS) have gained attention as a viable substitute for traditional drug administration methods because of their controlled release capabilities and non-invasive design. Microneedles are a new and effective technology that has attracted a lot of attention recently to enhance the capabilities of TDDS further. The study on microneedles and their potential to improve transdermal medication delivery is thoroughly reviewed in this review article. The study initiates by clarifying the difficulties linked to traditional medication delivery techniques and the benefits provided by transdermal channels. The article then explores the development of microneedle technology, outlining the several kinds of microneedles-solid, hollow, and dissolving-as well as their uses. Because of their special capacity to penetrate the skin's protective layer painlessly and their ability to distribute drugs precisely and accurately, microneedles are a highly useful instrument in pharmaceutical research. The materials, geometry, and manufacturing processes that affect the design and creation of microneedles are critically analyzed and presented. The manuscript delves into the latest developments in microneedle technology, encompassing the utilization of biodegradable polymers, smart materials, and sensing components for in-the-moment monitoring. This analysis concludes by highlighting the noteworthy advancements in the field of microneedles and their potential to transform transdermal drug delivery systems. This thorough knowledge seeks to further the current discussion in pharmaceutical research, encouraging creativity and opening the door for the creation of safer, more effective drug delivery systems.
Antiviral Bioactive Compounds: Their Activities and Underlying Mechanisms Against Human Viral Infections Somnath Ghosh, Koushik Jana, Pijus Parua, Arnab Seth, Amlan Bishal, Biplab Debnath, Saroj Kumar Rout, Jitu Halder, Vineet Kumar Rai, Priyanka Dash, Chandan Das, Biswakanth Kar, Goutam Ghosh, Goutam Rath Recent Advances in Inflammation and Allergy Drug Discovery, 2025 Background: Viral infections continue to be a major global health issue, causing over five million fatalities and millions of hospitalizations every year. Existing vaccines and commonly used antiviral drugs often exhibit significant side effects and limited efficacy. In contrast, recent studies have shown that plant extracts and their bioactive compounds possess considerable antiviral activity, along with a favourable safety profile for long-term use. These findings have spurred increased interest in the discovery and development of novel plant-derived antiviral agents. Aim: This review emphasizes the significance of plant-derived antiviral compounds and their corresponding therapeutic targets. It provides a comprehensive overview of recent research on phytochemicals with potential antiviral activity against a wide range of viruses. By consolidating current findings, this review serves as a unified and up-to-date resource on contemporary plant-based antiviral bioactive compounds used in the treatment of human viral infections. Methodology: The antiviral efficacy of selected phytoactive compounds was analysed through detailed molecular mechanism studies, supported by in vitro and/or in vivo experimental models. Key herbs were reviewed for their active compounds and antiviral activities against specific viruses like influenza, HIV, HBV, HCV, HSV SARS-CoV-2, and measles. The study also analyzed the results, comparing their mechanisms of action, such as immune modulation, inhibition of viral entry, or interference with replication, while also discussing limitations and gaps in current research. Result: Evidence from the literature suggests that the notable selectivity of herbal bioactive compounds toward viral target proteins may underlie their antiviral activity. Additionally, findings from in silico, in vitro, and in vivo studies indicate that these compounds exert their effects by binding to specific host cell components, thereby protecting the host from viral infection. This review identifies and summarizes over 150 plant-derived antiviral bioactive compounds, along with their respective mechanisms of action, that have demonstrated efficacy against various selected viruses. Conclusion: Plant-derived compounds, such as alkaloids, flavonoids, phenolics, terpenoids, and coumarins, exhibit significant antiviral potential. Given the limited number of approved antiviral drugs, cellular and molecular evidence supports herbal bioactives as promising alternatives for developing effective antiviral therapies, offering a natural and safer approach to combating viral infections.
A Review of the Phytochemical and Pharmacological Characteristics of Hernandia nymphaeifolia Sumana Das, Afsana Khan, Amlan Bishal, Bratati Badyopadhya, Mohini Mondal, Aveek Datta, Shilpy Jha, Raneet Das, Biplab Debnath Journal of Natural Remedies, 2024 Since ancient times, medicinal plants have been the primary source of most medications. In actuality, a large number of the medications that are now on the market may be obtained either directly in extract form or in modified synthetic form. As phytoconstituents, which are employed by plants to carry out biological processes and defend us from predators like viruses, fungi, and other microbes, they are naturally able to produce goods that are helpful for humans. Hernandia nymphaeifolia is a traditional medicinal plant that is used in several traditional remedies to treat several ailments. The extracts from various portions of the plant have excellent therapeutic effectiveness. Numerous pharmacological investigations have demonstrated this plant’s capacity to display anti-cytotoxic, anti-inflammatory, anti-platelet aggregation, vasodilator, antioxidant, anti-microbial, and Ca2+ signalling properties. The current study covers a thorough examination of the plant’s systematic botanical position, phytochemical analysis, investigations into the plant’s pharmacological activity, and therapeutic uses.
